Opioid REceptors on Lymphocytes and Brain
Opioid REceptors on Lymphocytes and Brain
批准号:
7173433
负责人:
JEAN M BIDLACK
金额:
$11.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-02-01 至 2008-01-31
关键词:
AffinityAgonistAmino Acid Sequence HomologyAntibodiesAwardBindingBrainCD8B1 geneCell CycleCell surfaceCellsCocaineCocaine AbuseCollaborationsDopamineDrug abuseEducational process of instructingEnsureFentanylFlow CytometryFluoresceinFluoresceinsGoalsGrantHeroinHeroin AbuseHerpesviridaeHumanImmuneInterphase CellLabelLigandsLocalizedLymphocyteLymphocyte ActivationMentorsMethodsMorphine Derivatives Including CocaineMusNational Institute of Drug AbuseNucleus AccumbensOpioidOpioid ReceptorPeritoneal MacrophagesPharmaceutical PreparationsPhycoerythrinPopulationPostdoctoral FellowProceduresProductivityPropertyReceptor ActivationReceptor CellRegulationRelative (related person)ResearchResearch ActivityResearch PersonnelResearch TrainingSelf AdministrationSenior ScientistSenior Scientist AwardSignal TransductionStaining and LabelingStreptavidinStudentsT-Cell ReceptorT-LymphocyteTestingTimeTrainingTraining ActivityWagesWorkWritingchemokinechemokine receptordrug seeking behaviorkappa opioid receptorsmacrophagemu opioid receptorsnaltrindolenext generationnonhuman primatenovelpreventreceptorreceptor expressionresearch studytherapy developmentthymocyte
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
This K05 Senior Scientist Award is to support Dr. Jean M. Bidlack's research activities. The specific aim of this award is to provide Dr. Bidlack with some release time from grant writing, teaching and administrative responsibilities to cover her salary. This award will allow her to devote the majority of her time to research and the training of graduate students and postdoctoral fellows. Training activities will be supported by a NIDA Training Grant (T32 DA07232). Dr. Bidlack will expand her research background and expertise in studying the expression and regulation of opioid receptors on immune cells. Also, she will investigate whether a chemokine receptor expressed on human herpes virus -6 and -7 binds opioids, and if opioids alter chemokine activation of the receptor. This chemokine receptor, U51, shares considerable amino acid sequence homology and similarity with the kappa opioid receptor. In addition, ongoing studies directed at medications development for the treatment of heroin and cocaine abuse will continue. The working hypothesis for which we have produced experimental support is that compounds, which release dopamine from the nucleus accumbens, promote drug-seeking behavior and those, which prevent release of this transmitter, prevent drug-seeking behavior. It is known that kappa agonists and mu antagonists inhibit dopamine release in the nucleus accumbens. Studies are further defining properties of select compounds that make some ? agonists with varying activity at mu receptors better at reducing cocaine self-administration in nonhuman primates than other compounds. In collaboration with chemists and behaviorists, we are evaluated new opioids as potential pharmacotherapeutics for treating drug abuse. The goals of these three independent projects will be accomplished within the framework of two R01 grants, a R21 grant, and three subcontracts from NIDA. Collectively, these projects will provide new information on the localization and function of the multiple opioid receptors on immune cells and on the human herpes viruses -6 and -7. Also, they will advance efforts in developing drugs to treat cocaine and heroin abuse. The present proposal is being requested in order to provide the candidate with stability of support, which is necessary for her continued commitment to research in the field of drug abuse and to ensure her sustained high level of productivity as both a senior scientist, and as a mentor for trainees, who will be the next generation of drug abuse researchers.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Synthesis and pharmacology of 8-amino-3-[(tetrahydro-2-furanyl)methyl] benzomorphan.
8-氨基-3-[(四氢-2-呋喃基)甲基]苯并吗喃的合成和药理学。
DOI:
--
发表时间:
2003
期刊:
Yao xue xue bao = Acta pharmaceutica Sinica.
影响因子:
--
作者:
[Zhou,Qun, Duan,Wen-hu, Cohen,DanaJ, Bidlack,JeanM, Wentland,MarkP]
通讯作者:
Wentland,MarkP
Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.
6,7-吲哚/噻唑吗啡喃的合成和药理评价——左啡诺的进一步SAR。
DOI:
10.1021/jm0701674
发表时间:
2007
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Zhang,Ao, Li,Fuying, Ding,Chunyong, Yao,Qizhen, Knapp,BrianI, Bidlack,JeanM, Neumeyer,JohnL]
通讯作者:
Neumeyer,JohnL
DOI:
10.1016/j.seizure.2008.06.014
发表时间:
2009-01
期刊:
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
影响因子:
3
作者:
[Bidlack, Jean M., Morris, Harold H., III]
通讯作者:
Morris, Harold H., III
DOI:
10.1021/jm020429w
发表时间:
2003-02
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[M. Wentland;Y. Ye;C. Cioffi;R. Lou;Qun Zhou;Guoyou Xu;W. Duan;C. Dehnhardt;Xufeng Sun;D. J. Cohen;J. Bidlack]
通讯作者:
M. Wentland;Y. Ye;C. Cioffi;R. Lou;Qun Zhou;Guoyou Xu;W. Duan;C. Dehnhardt;Xufeng Sun;D. J. Cohen;J. Bidlack
DOI:
10.1016/j.bmcl.2008.10.134
发表时间:
2009
期刊:
Bioorganic & medicinal chemistry letters
影响因子:
2.7
作者:
[M. Wentland;R. Lou;Qun Lu;Yigong Bu;Melissa A. VanAlstine;D. J. Cohen;J. Bidlack]
通讯作者:
M. Wentland;R. Lou;Qun Lu;Yigong Bu;Melissa A. VanAlstine;D. J. Cohen;J. Bidlack
共 25 条
G alpha Z subunit as a potential therapeutic target to modulate mu opioid receptor pharmacology
-
批准号:10580415
-
项目类别:
-
资助金额:$42.35万
-
财政年份:2022
-
负责人:JEAN M BIDLACK
-
依托单位:
38th Annual International Narcotics Research Conference
-
批准号:7334676
-
项目类别:
-
资助金额:$4.0万
-
财政年份:2007
-
负责人:JEAN M BIDLACK
-
依托单位:
37th Annual International Narcotics Research Conference
-
批准号:7167690
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2006
-
负责人:JEAN M BIDLACK
-
依托单位:
36th Annual International Narcotics Research Conference
-
批准号:7005344
-
项目类别:
-
资助金额:$6.5万
-
财政年份:2005
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid Binding to U51: A Human herpes Virus Protein
-
批准号:6447741
-
项目类别:
-
资助金额:$15.95万
-
财政年份:2001
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid Binding to U51: A Human herpes Virus Protein
-
批准号:6523577
-
项目类别:
-
资助金额:$15.95万
-
财政年份:2001
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid REceptors on Lymphocytes and Brain
-
批准号:6573588
-
项目类别:
-
资助金额:$11.54万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid REceptors on Lymphocytes and Brain
-
批准号:6848731
-
项目类别:
-
资助金额:$11.93万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid REceptors on Lymphocytes and Brain
-
批准号:6702541
-
项目类别:
-
资助金额:$11.84万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid REceptors on Lymphocytes and Brain
-
批准号:7017098
-
项目类别:
-
资助金额:$11.93万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID RECEPTORS ON LYMPHOCYTES AND BRAIN
-
批准号:6350466
-
项目类别:
-
资助金额:$9.57万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID RECEPTORS ON LYMPHOCYTES AND BRAIN
-
批准号:2544645
-
项目类别:
-
资助金额:$8.63万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID RECEPTORS ON LYMPHOCYTES AND BRAIN
-
批准号:6028177
-
项目类别:
-
资助金额:$9.29万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID RECEPTORS ON LYMPHOCYTES AND BRAIN
-
批准号:2872041
-
项目类别:
-
资助金额:$8.89万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID RECEPTORS ON LYMPHOCYTES AND BRAIN
-
批准号:6497771
-
项目类别:
-
资助金额:$11.3万
-
财政年份:1998
-
负责人:JEAN M BIDLACK
-
依托单位:
OMMITTED
-
批准号:2558986
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1995
-
负责人:JEAN M BIDLACK
-
依托单位:
OMMITTED
-
批准号:2388771
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1995
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID MODULATION OF IMMUNOCOMPETENCE
-
批准号:2117147
-
项目类别:
-
资助金额:$20.16万
-
财政年份:1989
-
负责人:JEAN M BIDLACK
-
依托单位:
Opioid Modulation of Immunocompetence
-
批准号:6603907
-
项目类别:
-
资助金额:$27.91万
-
财政年份:1989
-
负责人:JEAN M BIDLACK
-
依托单位:
OPIOID MODULATION OF IMMUNOCOMPETENCE
-
批准号:2117146
-
项目类别:
-
资助金额:$19.26万
-
财政年份:1989
-
负责人:JEAN M BIDLACK
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: